LianBio Statistics
Total Valuation
LianBio has a market cap or net worth of $30.33 million. The enterprise value is -$218.23 million.
Market Cap | 30.33M |
Enterprise Value | -218.23M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
LianBio has 107.17 million shares outstanding. The number of shares has decreased by -1.09% in one year.
Shares Outstanding | 107.17M |
Shares Change (YoY) | -1.09% |
Shares Change (QoQ) | +0.00% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.15 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.06, with a Debt / Equity ratio of 0.01.
Current Ratio | 10.06 |
Quick Ratio | 9.88 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -38.10% and return on invested capital (ROIC) is -51.93%.
Return on Equity (ROE) | -38.10% |
Return on Assets (ROA) | -30.20% |
Return on Capital (ROIC) | -51.93% |
Revenue Per Employee | n/a |
Profits Per Employee | -$539,761 |
Employee Count | 163 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, LianBio has paid $874,000 in taxes.
Income Tax | 874,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.33% in the last 52 weeks.
Beta (1Y) | n/a |
52-Week Price Change | -86.33% |
50-Day Moving Average | 2.38 |
200-Day Moving Average | 2.82 |
Relative Strength Index (RSI) | 10.59 |
Average Volume (30 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -106.56M |
Pretax Income | -87.11M |
Net Income | -87.98M |
EBITDA | -85.86M |
EBIT | -87.11M |
Earnings Per Share (EPS) | -$0.81 |
Balance Sheet
The company has $252.22 million in cash and $2.84 million in debt, giving a net cash position of $249.38 million or $2.33 per share.
Cash & Cash Equivalents | 252.22M |
Total Debt | 2.84M |
Net Cash | 249.38M |
Net Cash Per Share | $2.33 |
Equity / Book Value | 202.34M |
Book Value Per Share | 1.89 |
Working Capital | 232.18M |
Cash Flow
In the last 12 months, operating cash flow was -$83.53 million and capital expenditures -$464,000, giving a free cash flow of -$83.99 million.
Operating Cash Flow | -83.53M |
Capital Expenditures | -464,000 |
Free Cash Flow | -83.99M |
FCF Per Share | -$0.78 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
LianBio does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 1.09% |
Shareholder Yield | 1.09% |
Earnings Yield | -282.41% |
FCF Yield | -269.60% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |